Evidence map›Paper›PMID 28440480›Full record

ArticleMolecular medicine reports2017

Palmitate impairs angiogenesis via suppression of cathepsin activity.

Jin Zhang, Ying Shan, Yong Li, Xinping Luo, Haiming Shi

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Lung surfactant reducesMicrobiology spectrum · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. AqueousJournal of diabetes and metabolic disorders · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jin ZhangDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Ying ShanDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Yong LiDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Xinping LuoDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Haiming ShiDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Fudan University · CNHuashan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis requires the interaction of multiple variable factors to promote endothelial cell adhesion, migration and survival. Palmitate, a free fatty acid, exhibits an anti‑angiogenic effect via interference with endothelial cell function, whereas cysteine proteases are important in protein turnover and are termed positive modulators of neovascularization. However, the association between these two factors regarding the regulation of human endothelial cell function remains to be elucidated. By using cell counting kit‑8, the Transwell method and an annexin V‑fluorescein isothiocyanate/propidium iodide apoptosis detection kit, the present study reported that high levels of palmitate result in a significant decrease in endothelial cell proliferation and invasion, and induced cell apoptosis; cathepsin L and S inhibitors may suppress palmitate‑induced apoptosis. Conversely, the results of the cathepsin L and S activity assay and reverse-transcription-quantitative polymerase chain reaction indicated that palmitate inhibited cathepsin‑induced endothelial cell invasion, partially via suppressing the expression and activity of cathepsin L and S. The findings of the present study suggested that the potent anti‑angiogenic properties of palmitate may be mediated by cysteine proteases.

Indexed as

Angiogenesis InhibitorsApoptosisCathepsinsCell ProliferationCells, CulturedCell SurvivalCysteine ProteasesHumansHuman Umbilical Vein Endothelial CellsNeovascularization, PhysiologicPalmitatesProtease InhibitorsAngiogenesis InhibitorsCathepsinsCysteine ProteasesPalmitatesProtease Inhibitors

Identifiers

PMID28440480
PMCPMC5436153
OpenAlexW2606564262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.